Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare progression-free survival following therapy with single agent ofatumumab versus single agent rituximab in subjects with iNHL that has relapsed after prior rituximab-containing therapy.
Critère d'inclusion
- Indolent B-cell Non-Hodgkin’s Lymphoma